Extract
From the 1990s, five national programmes were carried out in Finland to respond to respiratory health challenges [1–6]. Previous experience from tuberculosis facilitated the launch of other initiatives. The programmes were implemented in the national public healthcare. Importantly, professional associations, non-governmental patient organisations (NGOs) and pharmacies contributed to the change of clinical practices.
抽象的
A nationwide, long-term and systematic lung health policy has been implemented in Finland. The real-world data indicate that the burden of respiratory diseases has reduced both for patients and, overall, for society.https://bit.ly/3lvpjjv
脚注
数据共享声明:本研究中分析的数据无法直接提供其他人。任何人都可以申请从Findata和相关医院区报告的数据的学习许可和访问。其他相关文件(包括本研究的备忘录和计划(主要是芬兰))将在向相应作者出版后两年可为研究人员提供。
Author contributions: F. Herse, R-L. Leskelä, T. Mattila and V. Jormanainen collected and analysed most of the data. T. Mattila outlined the first version of the manuscript. All authors interpreted the data, contributed to the writing process, and have read and agreed to the published version of the manuscript.
Conflict of interest: The corresponding author T. Mattila completed this study through financial support from the Hospital District of Helsinki and Uusimaa. All other co-authors completed the work related to this study as a function of their regular duties. Outside the submitted work, T. Mattila reports consulting fees from National Institute for Health and Welfare and Helsinki University; lecture fees from GlaxoSmithKline, Boehringer Ingelheim and AstraZeneca; support for attending congress from Boehringer Ingelheim and AstraZeneca; and participation on advisory boards for GlaxoSmithKline. T. Vasankari reports lecture fees from MSD and BI; and is a member of the board for ASH Finland. S. Toppila-Salmi reports grants from GSK; consultancy fees from AstraZeneca, ERT, Novartis, Sanofi Pharma and Roche Products. T. Haahtela reports lecture fees from GSK, Mundipharma, Orion Pharma and Sanofi. All other authors have no further disclosures outside the submitted work.
支持声明:芬兰卫生与福利研究所资助了数据收集。赫尔辛基医院和Uusimaa医院区的财政支持授予第一作者允许写我们的分析。本文的资金信息已存入Crossref Funder Registry.
- 已收到2022年1月13日。
- AcceptedMay 12, 2022.
- 版权所有©作者2022。用于复制权和权限联系权限{at} ersnet.org